4

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
Nov 27, 2019
Document Date
Nov 25, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
KemPharm
Issuer
KEMPHARM, INC
Filer
CLIFTON R. LADUANE